Researchers have developed a three-dimensional ‘organ on a chip’ which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research.
A new easy-to-use legal tool that enables exchange of biological material between research institutes and companies launches today.
Scientists hope that a new approach to vaccine development, combined with improved surveillance of potential future threats of outbreak, could help to massively reduce the impact of deadly diseases such as Ebola, Marburg and Lassa fever.
A Cambridge start-up has developed a low-cost next-generation wearable heart and cardiovascular function monitor which uses AI to diagnose heart rhythm and respiratory problems in real time.
In a warehouse to the northeast of Cambridge are shelves upon shelves of trays teeming with maggots, munching their way through a meal of rotting fruit and vegetables. This may sound stomach-churning, but these insects could become the sustainable food of the future – at least for fish and animals – helping reduce the reliance on resource intensive proteins such as fishmeal and soy, while also mitigating the use of antibiotics in the food chain, one of the causes of the increase in drug-resistant bacteria.
The Prince of Wales Global Sustainability Fellowship Programme represents a multi-million-pound commitment from the private sector to accelerate progress on UN Sustainable Development Goals.
Entries are now open for the Unilever Young Entrepreneurs Awards, supporting and celebrating inspirational young people from all over the world who have initiatives, products or services that tackle the planet’s biggest sustainability challenges.
The University of Cambridge has signed an agreement with one of China’s largest universities to encourage innovation and entrepreneurship in one of China’s fastest-growing high-tech clusters.
The UK’s fastest academic supercomputer, based at the University of Cambridge, will be made available to artificial intelligence (AI) technology companies from across the UK, in support of the government’s industrial strategy.
Almost 30 years on from the discovery of the genetic defect that causes cystic fibrosis, treatment options are still limited and growing antibiotic resistance presents a grave threat. Now, a team of researchers from across Cambridge, in a major new centre supported by the Cystic Fibrosis Trust, hopes to turn fortunes around.